Zum Beitrag: Screening auf ADHS bei Adipositas im Kindes- und Jugendalter

Mit großem Interesse las ich den Beitrag „Diagnostik und Therapie bei Adipositas und extremer Adipositas im Kindes- und Jugendalter“ von Prof. Reinehr [1] – aus meiner Sicht sind aber einige Ergänzungen zu dem Beitrag essenziell.

Publication History

Article published online:
02 December 2020

• Literatur

• 1 Reinehr T. Diagnostik und Therapie bei Adipositas und extremer Adipositas im Kindes- und Jugendalter. Pädiatrie up2date 2020; 15: 107-125
• 2 Altfas JR. Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry 2002; 2: 9
• 3 Cortese S, Moreira-Maia CR, St Fleur D. et al. Association Between ADHD and Obesity: A Systematic Review and Meta-Analysis. Am J Psychiatry 2016; 173: 34-43
• 4 Hanć T, Cortese S. Attention deficit/hyperactivity-disorder and obesity.: A review and model of current hypotheses explaining their comorbidity. Neurosci Biobehav Rev 2018; 92: 16-28
• 5 Chen Q, Kuja-Halkola R, Sjölander A. et al. Shared familial risk factors between attention-deficit/hyperactivity disorder and overweight/obesity – a population-based familial coaggregation study in Sweden. J Child Psychol Psychiatry 2017; 58: 711-718
• 6 Chen Q, Hartman CA, Kuja-Halkola R. et al. Attention-deficit/hyperactivity disorder and clinically diagnosed obesity in adolescence and young adulthood: a register-based study in Sweden. Psychol Med 2019; 49: 1841-1849
• 7 Demontis D, Walters RK, Martin J. et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet 2019; 51: 63-75
• 8 Barker ED, Ing A, Biondo F. et al. Do ADHD-impulsivity and BMI have shared polygenic and neural correlates?. Mol Psychiatry 2019; DOI: 10.1038/s41380-019-0444-y.
• 9 Cortese S, Ramos Olazagasti MA, Klein RG. et al. Obesity in men with childhood ADHD: A 33-year controlled, prospective, follow-up study. Pediatrics 2013; 131: e1731-e1738
• 10 Khalife N, Kantomaa M, Glover V. et al. Childhood attention-deficit/hyperactivity disorder symptoms are risk factors for obesity and physical inactivity in adolescence. J Am Acad Child Adolesc Psychiatry 2014; 53: 425-436
• 11 Cortese S, Vincenzi B. Obesity and ADHD: Clinical and neurobiological implications. Curr Top Behav Neurosci 2012; 9: 199-218
• 12 Davis C, Levitan RD, Smith M. et al. Associations among overeating, overweight, and attention deficit/hyperactivity disorder: a structural equation modelling approach. Eat Behav 2006; 7: 266-274
• 13 Shefer G, Marcus Y, Stern N. Is obesity a brain disease?. Neurosci Biobehav Rev 2013; 37: 2489-2503
• 14 Levy LD, Fleming JP, Klar D. Treatment of refractory obesity in severely obese adults following management of newly diagnosed attention deficit hyperactivity disorder. Int J Obes 2009; 33: 326-334
• 15 Pagoto SL, Curtin C, Lemon SC. et al. Association between adult attention deficit/hyperactivity disorder and obesity in the US population. Obesity (Silver Spring) 2009; 17: 539-544
• 16 Schweickert LA, Strober M, Moskowitz A. Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report. Int J Eat Disord 1997; 21: 299-301
• 17 Strimas R, Davis C, Patte K. et al. Symptoms of attention-deficit/hyperactivity disorder, overeating, and body mass index in men. Eat Behav 2008; 9: 516-518
• 18 Granato MF, Ferraro AA, Lellis DM. et al. Associations between Attention-Deficit Hyperactivity Disorder (ADHD) Treatment and Patient Nutritional Status and Height. Behav Neurol 2018; 2018: 7341529
• 19 Blum K, Braverman ER, Holder JM. et al. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive and compulsive behaviors. J Psychoactive Drugs 2000; 32 (Suppl. 01) 1-112
• 20 Davis C. Psychobiological traits in the risk profile for overeating and weight gain. Int J Obesity 2000; 33 (Suppl. 02) 49-53
• 21 Mellstrom E, Forsmann C, Engh L. et al. Methylphenidate and Reduced Overweight in Children with ADHD. J Atten Disord 2020; 24: 246-254
• 22 Chang Z, Lichtenstein P, Halldner L. et al. Stimulant ADHD medication and risk for substance abuse. J Child Psychol Psychiatry 2014; 55: 878-885
• 23 Griffiths KR, Yang J, Touyz SW. et al. Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol. J Eat Dis 2019; 7: 23
• 24 Akmatov MK, Ermakova T, Bätzing J. Psychiatric and Nonpsychiatric Comorbidities Among Children With ADHD: An Exploratory Analysis of Nationwide Claims Data in Germany. J Atten Dis 2019; DOI: 10.1177/1087054719865779.
• 25 Alabaf S, Gillberg C, Lundström S. et al. Physical health in children with neurodevelopmental disorders. J Autism Dev Disord 2019; 49: 83-95
• 26 Brunault P, Frammery J, Montaudon P. et al. Adulthood and childhood ADHD in patients consulting for obesity is associated with food addiction and binge eating, but not sleep apnea syndrome. Appetite 2019; 136: 25-32
• 27 Cortese S, Castellanos FX. The relationship between ADHD and obesity: Implications for therapy. Expert Rev Neurother 2014; 14: 473-479